Video content material above is prompted by the next query:
- Please touch upon the affected person inhabitants, research design, and key aims from the part 3 TROPION-Breast01 research of datopotamab deruxtecan (Dato-DXd) in sufferers with HR+/HER2- metastatic breast most cancers.
